Pharmaceuticals in Turkey
Summary
Pharmaceuticals in Turkey industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2019-24, and forecast to 2029). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
Pharmaceuticals in Turkey industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2019-24, and forecast to 2029). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The pharmaceutical market includes sales of both prescriptions and over-the-counter (OTC) drugs. The market scope does not cover consumer healthcare and animal health products.
- The Turkish pharmaceuticals market recorded revenues of $8.0 billion in 2024, representing a compound annual growth rate (CAGR) of 3.0% between 2019 and 2024.
- The anti-infective drugs segment accounted for the market's largest proportion in 2024, with total revenues of $1.0 billion, equivalent to 12.4% of the market's overall value.
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pharmaceuticals market in Turkey
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Turkey
- Leading company profiles reveal details of key pharmaceuticals market players? global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Turkey pharmaceuticals market with five year forecasts by both value and volume
- What was the size of the Turkey pharmaceuticals market by value in 2024?
- What will be the size of the Turkey pharmaceuticals market in 2029?
- What factors are affecting the strength of competition in the Turkey pharmaceuticals market?
- How has the market performed over the last five years?
- Who are the top competitors in Turkey's pharmaceuticals market?
1 EXECUTIVE SUMMARY
1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Market rivalry
1.6. Competitive landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
4 MARKET SEGMENTATION
4.1. Category segmentation
4.2. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Who are the leading players?
7.2. What are the strategies of the leading players?
7.3. What are the most recent market developments?
8 COMPANY PROFILES
8.1. Novartis AG
8.2. Abdi Ibrahim Ilac Sanayi ve Ticaret AS
8.3. Deva Holding AS
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Market rivalry
1.6. Competitive landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
4 MARKET SEGMENTATION
4.1. Category segmentation
4.2. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Who are the leading players?
7.2. What are the strategies of the leading players?
7.3. What are the most recent market developments?
8 COMPANY PROFILES
8.1. Novartis AG
8.2. Abdi Ibrahim Ilac Sanayi ve Ticaret AS
8.3. Deva Holding AS
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
LIST OF TABLES
Table 1: Turkey pharmaceuticals market value: $ million, 2019-24
Table 2: Turkey pharmaceuticals market category segmentation: % share, by value, 2019-24
Table 3: Turkey pharmaceuticals market category segmentation: $ million, 2019-24
Table 4: Turkey pharmaceuticals market geography segmentation: $ million, 2024
Table 5: Turkey pharmaceuticals market value forecast: $ million, 2024-29
Table 6: Novartis AG: Key Facts
Table 7: Novartis AG: Annual Financial Ratios
Table 8: Novartis AG: Key Employees
Table 9: Abdi Ibrahim Ilac Sanayi ve Ticaret AS: Key Facts
Table 10: Abdi Ibrahim Ilac Sanayi ve Ticaret AS: Key Employees
Table 11: Deva Holding AS: Key Facts
Table 12: Deva Holding AS: Annual Financial Ratios
Table 13: Deva Holding AS: Key Employees
Table 14: Turkey Size of Population (Million), 2020-24
Table 15: Turkey Real GDP (Constant 2010 Prices, $ Billion), 2020-24
Table 16: Turkey GDP (Current Prices, $ Billion), 2020-24
Table 17: Turkey Inflation, 2020-24
Table 18: Turkey Consumer Price Index (Absolute), 2020-24
Table 19: Turkey Exchange Rate, 2019-24
Table 1: Turkey pharmaceuticals market value: $ million, 2019-24
Table 2: Turkey pharmaceuticals market category segmentation: % share, by value, 2019-24
Table 3: Turkey pharmaceuticals market category segmentation: $ million, 2019-24
Table 4: Turkey pharmaceuticals market geography segmentation: $ million, 2024
Table 5: Turkey pharmaceuticals market value forecast: $ million, 2024-29
Table 6: Novartis AG: Key Facts
Table 7: Novartis AG: Annual Financial Ratios
Table 8: Novartis AG: Key Employees
Table 9: Abdi Ibrahim Ilac Sanayi ve Ticaret AS: Key Facts
Table 10: Abdi Ibrahim Ilac Sanayi ve Ticaret AS: Key Employees
Table 11: Deva Holding AS: Key Facts
Table 12: Deva Holding AS: Annual Financial Ratios
Table 13: Deva Holding AS: Key Employees
Table 14: Turkey Size of Population (Million), 2020-24
Table 15: Turkey Real GDP (Constant 2010 Prices, $ Billion), 2020-24
Table 16: Turkey GDP (Current Prices, $ Billion), 2020-24
Table 17: Turkey Inflation, 2020-24
Table 18: Turkey Consumer Price Index (Absolute), 2020-24
Table 19: Turkey Exchange Rate, 2019-24
LIST OF FIGURES
Figure 1: Turkey pharmaceuticals market value: $ million, 2019-24
Figure 2: Turkey pharmaceuticals market category segmentation: $ million, 2019-24
Figure 3: Turkey pharmaceuticals market geography segmentation: % share, by value, 2024
Figure 4: Turkey pharmaceuticals market value forecast: $ million, 2024-29
Figure 5: Forces driving competition in the pharmaceuticals market in Turkey, 2024
Figure 6: Drivers of buyer power in the pharmaceuticals market in Turkey, 2024
Figure 7: Drivers of supplier power in the pharmaceuticals market in Turkey, 2024
Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Turkey, 2024
Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in Turkey, 2024
Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in Turkey, 2024
Figure 1: Turkey pharmaceuticals market value: $ million, 2019-24
Figure 2: Turkey pharmaceuticals market category segmentation: $ million, 2019-24
Figure 3: Turkey pharmaceuticals market geography segmentation: % share, by value, 2024
Figure 4: Turkey pharmaceuticals market value forecast: $ million, 2024-29
Figure 5: Forces driving competition in the pharmaceuticals market in Turkey, 2024
Figure 6: Drivers of buyer power in the pharmaceuticals market in Turkey, 2024
Figure 7: Drivers of supplier power in the pharmaceuticals market in Turkey, 2024
Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Turkey, 2024
Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in Turkey, 2024
Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in Turkey, 2024
